NutrAward Winner Features ‘New Vitamin’ PQQ from Maypro Industries

Mar. 17, 2010 – PURCHASE, N.Y. – VitaPQQTM, a finished product containing the ingredient PQQ from Maypro Industries, has been named winner of the prestigious NutrAward as the Best New Evidence-Based Finished Product of the Year at the Expo West, the industry’s largest trade show that drew over 56,000 attendees and over 1,800 exhibitors.

“We are very proud that an ingredient that Maypro introduced into the U.S. market has been recognized by our industry peers” said Steve Yamada, the Founder and President of Maypro. “This validates Maypro’s strategic focus over the past 32 years on introducing truly innovative clini- cally proven ingredients developed in one market into other world markets.”

This marks the third time in the last 8 years that an ingredient marketed by Maypro has received the Nutracon award, considered to be one the industry’s top honors for new ingredients and finished products. Prior award winners from Maypro include AHCC®, a proprietary medicinal mushroom based compound recognized in 2002 and Oligonol® - theworld’s first commercially available low-molecular-weight polyphenol recognized in 2007. Detailed informa- tion about the NutrAward can be found at www.NutrAward.com.

About PQQ

The discovery of compound PQQ was first reported in the journal Science in 1979 and in 2003, an article in the journal Nature classified PQQ is a newcome to the Vitamin B family, making it the first new vitamin discovered since 1948. Recent findings have shown that PQQ is a component of interstellar dust, considered to be a precur- sor of organic materials in early life on Earth which also points to PQQ’s evolutionary importance to the devel- opment of life forms.

Manufactured using a unique patented process, the ingredient PQQ is marketed in North America by Maypro and is now backed by several clinical studies and by over 175 PubMed listed published studies. These studies have demonstrated in animal models, that PQQ can improve the number and function of the mitochondria and can pro- tect mitochondria from damage.* Similar compounds such as resveratrol which have been shown also in animal studies to have a similar mode of action as PQQ pertaining to mitochondrial biogenesis, have generated significant sales in the supplement industry and have become subject of research by major pharmaceutical companies.

Clinically proven health benefits of PQQ include improved cognitive function. A recently published double- blind placebo-controlled clinical study on 70 subjects has shown that PQQ improves short-term memory, men- tal focus and cognitive agility. A more recent double-blind placebo-controlled study on 63 elderly volunteers showed improvement in short-term memory, with particularly strong benefits in memory-compromised indi- viduals. Another open label study on 17 subjects showed that PQQ improves the quality of sleep and supports a positive mood.

PQQ has been accepted as a New Dietary Ingredient by the FDA and further regulatory approvals are being sought in select international markets.

The distribution of the ingredient PQQ in the US is being developed via channel-specific licenses with major pharmaceutical, multi-level marketing (MLM) and direct mail companies. For more information, please contact Maypro Industries at (914) 251-0701.

About Maypro

Serving the nutritional industry for over 30 years, Maypro Group is global supplier of nutraceutical ingredients to the nutritional supplement, sports nutrition, pet & veterinary, cosmetic, functional food and fine chemical industries. Maypro is a minority-owned affiliate of Marubeni Corporation, one of Japan’s largest conglomerates with over US$80 billion in annual revenues and offices in 125 countries worldwide.

Maypro is headquartered in Purchase, N.Y., and has offices in Tokyo and Shanghai. Maypro represents some of the world’s largest nutraceutical ingredient manufacturers and supplies high-quality ingredients in the U.S., Japan, Europe, Latin America and throughout Asia.

Maypro has established itself as an industry innovator. It was the first company to introduce into the U.S. such leading ingredients as Coenzyme Q10 (CoQ10), chondroitin, glucosamine, L-carnitine, alpha-lipoic acid and AHCC®.For more information, please visit the Maypro Web site at www.maypro.com.

###

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or mitigate disease.